Menu
1 min read · estimated
APPROVED USE
What FDA approved
With pembrolizumab and platinum chemotherapy for initial treatment of metastatic nonsquamous NSCLC without EGFR or ALK genomic tumor aberrations.
LAMPGEN ANALYSIS
Why it matters
This approval adds the first-line chemoimmunotherapy use to the Axtle pemetrexed label.
What research teams should watch
Verify histology and driver testing and build folate and vitamin B12 supplementation into treatment preparation.
PRIMARY RECORDS